First China Pharmaceutical Group (FCPG) Inventory Turnover Ratio, from third quarter 2012 to third quarter 2011, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
First China Pharmaceutical Group, Inc.  (FCPG)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

First China Pharmaceutical Group Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2012, First China Pharmaceutical Group's inventory turnover ratio sequentially decreased to 37.93 in the third quarter 2012, unsurprisingly, as the First China Pharmaceutical Group markets continue to deteriorate, and FCPG's faces growing challenges to bring down its inventories. First China Pharmaceutical Group's average inventory processing period in the Sep 30 2012 quarter, has increased to 10 days, from 6 days, in the Jun 30 2012 quarter.

Within Healthcare sector 7 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 0 in the second quarter 2012, to 138.

FCPG Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is First China Pharmaceutical Group, Inc. Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FCPG Inventory Turnover Ratio (Sep 30 2012)
III. Quarter		 (Jun 30 2012)
II. Quarter		 (Mar 31 2012)
I. Quarter		 (Sep 30 2011)
III. Quarter		 (Jun 30 2011)
II. Quarter
Y / Y Inventory Growth 199.18 % -51.28 % -84.2 % -89.77 % -74.59 %
Y / Y Cost of Sales Growth 51.91 % 106.58 % 93.2 % 122.76 % -
Inventory Turnover Ratio (TTM) 37.93 59.43 42.64 19.11 8.25
FCPG's Total Ranking # 138 # 0 # 0 # #
Average inventory processing period 10 6 9 19 44
Seq. Inventory Growth 481.94 % -9.17 % -4.98 % -40.43 % -5.24 %
Seq. Cost of Sales Growth 24.43 % 12.92 % -15.74 % 28.31 % 69.21 %




Inventory Turnover Ratio Company Ranking
Within: No.
Healthcare Facilities Industry # 4
Healthcare Sector # 8
Overall Market # 138

Inventory Turnover Ratio Statistics
High Average Low
37.93 37.93 37.93
(Sep 30 2012)  



FCPG Company Profile >> Back to FCPG Efficiency Comparisons >> Compare FCPG Inventory Turnover Ratio to its Competitors

Financial Statements
First China Pharmaceutical Group's Inventories $ 4 Millions Visit FCPG's Balance sheet
First China Pharmaceutical Group's Cost of Revenues TTM $ 53 Millions Visit FCPG's Income Statement
What are FCPG's Sales? Visit FCPG's Sales by Segment

Other Inventory Turnover Ratios
First China Pharmaceutical Group's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Healthcare Facilities Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
FCPG's Inventory Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for FCPG's Competitors
Inventory Turnover Ratio for FCPG's Suppliers
Inventory Turnover Ratio for FCPG's Customers

You may also want to know
FCPG's Sales Growth Rates FCPG's Pe Price to earnings ratio FCPG's Receivables Turnover Ratio FCPG's Stock Quote
FCPG's Net Income Growth Rates FCPG's Ps Price to Sales ratio FCPG's Sales per Employee FCPG's Asset Turnover Ratio
FCPG's Net Margin FCPG's Pb Price to Book ratio FCPG's Financial Strength Ratios FCPG's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2012, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2012 Inventories at quarter ending Sep 30 2012
First China Pharmaceutical Group, Inc.  37.93 $ 52.537  Millions$ 1  Millions
Labcorp Holdings Inc   29.92 $ 3,370.900  Millions$ 113  Millions
Healthcare Services Group Inc   26.22 $ 691.983  Millions$ 26  Millions
Cryoport inc   20.93 $ 1.043  Millions$ 0  Millions
Agenus Inc  18.57 $ 0.369  Millions$ 0  Millions
Rockwell Medical inc   16.31 $ 42.204  Millions$ 3  Millions
Aim Immunotech Inc   14.18 $ 13.860  Millions$ 1  Millions
Insulet Corporation  11.86 $ 172.067  Millions$ 15  Millions
Veru Inc   10.46 $ 10.251  Millions$ 1  Millions
Wearable Health Solutions, Inc.  10.19 $ 0.480  Millions$ 0  Millions
Dyne Therapeutics Inc   9.94 $ 626.000  Millions$ 63  Millions
Option Care Health Inc   9.89 $ 317.332  Millions$ 32  Millions
Tenet Healthcare Corp  9.82 $ 1,562.000  Millions$ 159  Millions
Igc Pharma Inc   8.90 $ 3.071  Millions$ 0  Millions
Mit Holding, Inc.  8.89 $ 1.354  Millions$ 0  Millions
Inotiv Inc   8.20 $ 14.592  Millions$ 2  Millions
Align Technology inc   8.16 $ 107.291  Millions$ 13  Millions
Hill rom Holdings Inc   8.12 $ 879.600  Millions$ 108  Millions
Antares Pharma Inc   7.92 $ 7.818  Millions$ 1  Millions
Protalix Biotherapeutics inc   7.68 $ 6.966  Millions$ 1  Millions
Patterson Companies Inc   7.42 $ 2,418.228  Millions$ 326  Millions
Fonar Corporation  7.31 $ 21.667  Millions$ 3  Millions
Ufp Technologies Inc   7.17 $ 69.474  Millions$ 10  Millions
China Pediatric Pharmaceuticals, Inc.  7.17 $ 3.294  Millions$ 0  Millions
Bioxytran Inc   6.95 $ 0.096  Millions$ 0  Millions
Bohai Pharmaceuticals Group, Inc.  6.82 $ 25.093  Millions$ 4  Millions
China Yct International Group, Inc.  6.61 $ 18.147  Millions$ 3  Millions
Camp4 Therapeutics Corporation  6.59 $ 82.620  Millions$ 13  Millions
Omnova Solutions Inc  6.59 $ 637.500  Millions$ 97  Millions
Cocrystal Pharma Inc   6.43 $ 14.101  Millions$ 2  Millions

Date modified: 2026-09-08T15:07:17+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.